C3ORF37 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.88178419700125E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.44789744030527E-11 |
Normal-vs-Stage2 |
1.58639990033294E-10 |
Normal-vs-Stage3 |
5.14810416518685E-13 |
Normal-vs-Stage4 |
4.28610036351529E-10 |
Stage1-vs-Stage2 |
2.811600E-02 |
Stage1-vs-Stage3 |
3.802400E-02 |
Stage1-vs-Stage4 |
3.885200E-01 |
Stage2-vs-Stage3 |
5.432400E-01 |
Stage2-vs-Stage4 |
1.358030E-01 |
Stage3-vs-Stage4 |
3.082600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62481139653892E-12 |
Normal-vs-AfricanAmerican |
4.23299999999793E-05 |
Normal-vs-Asian |
6.758200E-01 |
Caucasian-vs-AfricanAmerican |
1.821830E-01 |
Caucasian-vs-Asian |
2.280600E-01 |
AfricanAmerican-vs-Asian |
2.304800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
6.50700004989346E-09 |
Male-vs-Female |
7.573100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.022300E-03 |
Normal-vs-Age(41-60Yrs) |
2.00905958536168E-12 |
Normal-vs-Age(61-80Yrs) |
1.68520752907853E-12 |
Normal-vs-Age(81-100Yrs) |
1.80439996277926E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.965600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.808960E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.044700E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.274000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.158400E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.781100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.828400E-01 |
Normal-vs-Grade 2 |
1.82569515061459E-11 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
1.02630000053949E-08 |
Grade 1-vs-Grade 2 |
2.543700E-02 |
Grade 1-vs-Grade 3 |
9.445100E-04 |
Grade 1-vs-Grade 4 |
2.209800E-02 |
Grade 2-vs-Grade 3 |
2.116300E-02 |
Grade 2-vs-Grade 4 |
4.359800E-01 |
Grade 3-vs-Grade 4 |
4.498400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.00319996754195E-09 |
Normal-vs-ccB subtype |
6.77435885165778E-12 |
ccA subtype-vs-ccB subtype |
4.004200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
5.652500E-02 |
N0-vs-N1 |
2.058000E-02 |
|
|